Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 8
Submit an article Journal homepage
627
Views
12
CrossRef citations to date
0
Altmetric
Author's View

Myeloid-derived suppressor cells as a Trojan horse

A cellular vehicle for the delivery of oncolytic viruses

Ping-Ying Pan Department of Oncological Sciences; Icahn School of Medicine at Mount Sinai; New York, NY USA; Tisch Cancer Institute; Icahn School of Medicine at Mount Sinai; New York, NY USACorrespondence[email protected] [email protected]
,
Hui-ming Chen Department of Oncological Sciences; Icahn School of Medicine at Mount Sinai; New York, NY USA
&
Shu-Hsia Chen Department of Oncological Sciences; Icahn School of Medicine at Mount Sinai; New York, NY USA; Tisch Cancer Institute; Icahn School of Medicine at Mount Sinai; New York, NY USA; Immunology Institute; Icahn School of Medicine at Mount Sinai; New York, NY USACorrespondence[email protected] [email protected]
Article: e25083 | Received 15 May 2013, Accepted 17 May 2013, Published online: 28 May 2013

References

  • Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253 - 68; http://dx.doi.org/10.1038/nri3175; PMID: 22437938
  • Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 2013; 496:445 - 55; http://dx.doi.org/10.1038/nature12034; PMID: 23619691
  • Rodríguez PC, Ochoa AC. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives. Immunol Rev 2008; 222:180 - 91; http://dx.doi.org/10.1111/j.1600-065X.2008.00608.x; PMID: 18364002
  • Eisenstein S, Coakley BA, Briley-Saebo K, Ma G, Meseck M, Ward S, et al. Myeloid derived suppressor cells as a vehicle for tumor-specific oncolytic viral therapy. Cancer Res 2013; In press http://dx.doi.org/10.1158/0008-5472.CAN-12-1597; PMID: 23536556
  • Ma G, Pan PY, Eisenstein S, Divino CM, Lowell CA, Takai T, et al. Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 2011; 34:385 - 95; http://dx.doi.org/10.1016/j.immuni.2011.02.004; PMID: 21376641
  • Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012; 122:787 - 95; http://dx.doi.org/10.1172/JCI59643; PMID: 22378047
  • Yang WC, Ma G, Chen SH, Pan PY. Polarization and reprogramming of myeloid-derived suppressor cells. J Mol Cell Biol 2013; 5:207 - 9; http://dx.doi.org/10.1093/jmcb/mjt009; PMID: 23532593
  • Shime H, Matsumoto M, Oshiumi H, Tanaka S, Nakane A, Iwakura Y, et al. Toll-like receptor 3 signaling converts tumor-supporting myeloid cells to tumoricidal effectors. Proc Natl Acad Sci U S A 2012; 109:2066 - 71; http://dx.doi.org/10.1073/pnas.1113099109; PMID: 22308357
  • Chandra D, Jahangir A, Quispe-Tintaya W, Einstein MH, Gravekamp C. Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice. Br J Cancer 2013; In press http://dx.doi.org/10.1038/bjc.2013.206; PMID: 23640395
  • Zhou Z, French DL, Ma G, Eisenstein S, Chen Y, Divino CM, et al. Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells 2010; 28:620 - 32; PMID: 20073041

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.